PIP5K1α inhibition as a therapeutic strategy for prostate cancer.
Publication
, Journal Article
Drake, JM; Huang, J
Published in: Proc Natl Acad Sci U S A
September 2, 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Proc Natl Acad Sci U S A
DOI
EISSN
1091-6490
Publication Date
September 2, 2014
Volume
111
Issue
35
Start / End Page
12578 / 12579
Location
United States
Related Subject Headings
- Tetrahydroisoquinolines
- Prostatic Neoplasms
- Phosphotransferases (Alcohol Group Acceptor)
- Male
- Isoquinolines
- Indoles
- Humans
- Diketopiperazines
- Animals
Citation
APA
Chicago
ICMJE
MLA
NLM
Drake, J. M., & Huang, J. (2014). PIP5K1α inhibition as a therapeutic strategy for prostate cancer. Proc Natl Acad Sci U S A, 111(35), 12578–12579. https://doi.org/10.1073/pnas.1413363111
Drake, Justin M., and Jiaoti Huang. “PIP5K1α inhibition as a therapeutic strategy for prostate cancer.” Proc Natl Acad Sci U S A 111, no. 35 (September 2, 2014): 12578–79. https://doi.org/10.1073/pnas.1413363111.
Drake JM, Huang J. PIP5K1α inhibition as a therapeutic strategy for prostate cancer. Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12578–9.
Drake, Justin M., and Jiaoti Huang. “PIP5K1α inhibition as a therapeutic strategy for prostate cancer.” Proc Natl Acad Sci U S A, vol. 111, no. 35, Sept. 2014, pp. 12578–79. Pubmed, doi:10.1073/pnas.1413363111.
Drake JM, Huang J. PIP5K1α inhibition as a therapeutic strategy for prostate cancer. Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12578–12579.
Published In
Proc Natl Acad Sci U S A
DOI
EISSN
1091-6490
Publication Date
September 2, 2014
Volume
111
Issue
35
Start / End Page
12578 / 12579
Location
United States
Related Subject Headings
- Tetrahydroisoquinolines
- Prostatic Neoplasms
- Phosphotransferases (Alcohol Group Acceptor)
- Male
- Isoquinolines
- Indoles
- Humans
- Diketopiperazines
- Animals